Vitamin D3
Cholecalciferol · Colecalciferol · The Sunshine Vitamin
Last updated
At a glance
Overview
Vitamin D3 is the cheapest, most boring, most universally-run compound in the bodybuilding and looksmaxxing stack — and that's exactly why it matters. Fix a deficiency and you can pull total testosterone up by ~25%, tighten grip strength, shore up bone density under heavy orals, and give your immune system a floor that survives cutting phases and 5am cardio. Ignore it and you're leaving free T, recovery, and mood on the table for the sake of a supplement that costs roughly twelve cents a day.
The community runs D3 higher than the IOM's conservative RDA for a reason: the 600–800 IU/day official number is built around preventing rickets, not optimizing a 220-lb lifter's endocrine panel. Most physique-focused users settle at 5,000 IU/day with a fatty meal, paired reflexively with K2 (MK-7) and magnesium as cofactors, and target a serum 25(OH)D of 40–60 ng/mL on bloodwork. Obese users, heavy-muscled users, winter-indoor users, and dark-skinned users all need meaningfully more to land in that window.
"A significant increase in total testosterone levels was observed in the vitamin D supplemented group (from 10.7 ± 3.9 to 13.4 ± 4.7 nmol/l, p < 0.001), whereas in the placebo group there was no significant change." — Pilz et al., Hormone and Metabolic Research (2011)
The T-boosting effect is real but deficiency-dependent — if you're already replete, more D3 doesn't push testosterone further. Below we'll cover evidence-based dosing tiers, how to dial in 25(OH)D targets with bloodwork, the K2 + magnesium cofactor stack, how D3 fits into on-cycle protocols alongside AAS, and the narrow but important contraindications (sarcoidosis, hyperparathyroidism, hypercalcemia) where supplementation stops being harmless. Plus the mistakes that turn a near-perfect supplement into a hypercalciuria problem.
How Vitamin D3 works
From Prohormone to Active Hormone: The Two-Step Activation#
Cholecalciferol itself is biologically inert — it's a secosteroid prohormone, not the active molecule. When you swallow a D3 softgel (or synthesize it in skin from 7-dehydrocholesterol under UVB), it has to be hydroxylated twice before it does anything.
The liver converts D3 to 25-hydroxyvitamin D [25(OH)D, calcifediol] via CYP2R1. This is the storage form with a ~15-day half-life — and it's what your bloodwork measures when you order a "vitamin D" panel. The kidney (and, critically, many peripheral tissues including muscle, immune cells, and Leydig cells) then converts 25(OH)D to the active hormone 1,25-dihydroxyvitamin D [calcitriol] via CYP27B1.
This two-step structure is why dosing is forgiving — the ~15-day half-life of 25(OH)D means weekly or even monthly dosing works, and why it takes 8–12 weeks of consistent supplementation for blood levels to plateau. It's also why obese users under-respond: adipose tissue sequesters the parent compound before it can be hydroxylated.
"Vitamin D intoxication is observed most commonly after high chronic intakes and is characterized by hypercalcemia, hypercalciuria, and suppressed PTH concentration." — Jones G., American Journal of Clinical Nutrition (2008)
VDR Activation and Genomic Signalling#
Calcitriol binds the vitamin D receptor (VDR), a nuclear receptor that heterodimerizes with RXR and binds vitamin D response elements (VDREs) in DNA. This regulates transcription of roughly 3% of the human genome — calcium/phosphate handling, innate and adaptive immunity, cell-cycle control, and, relevant here, steroidogenic machinery.
VDR is not a niche receptor. It's expressed in skeletal muscle fibers, Leydig cells, seminiferous tubules, hair follicles, keratinocytes, and virtually every immune cell lineage. When 25(OH)D is low, VDR signalling across all these tissues runs at reduced capacity — which is the unifying explanation for why deficiency correlates with low T, poor recovery, weak immune response, and worse AGA outcomes simultaneously.
Testosterone and the Leydig Cell Connection#
VDR expression in testicular Leydig cells is the mechanistic hook for the testosterone story. Pilz's 2011 RCT — the most-cited data point in every "D3 raises T" community post — ran 3,332 IU/day for one year in overweight men with baseline deficiency:
"A significant increase in total testosterone levels was observed in the vitamin D supplemented group (from 10.7 ± 3.9 to 13.4 ± 4.7 nmol/l, p < 0.001), whereas in the placebo group there was no significant change." — Pilz S, Frisch S, Koertke H, et al., Hormone and Metabolic Research (2011)
The honest read: this effect is deficiency-dependent. Fixing a 15 ng/mL 25(OH)D can add meaningful free T. Pushing an already-replete 45 ng/mL guy to 70 ng/mL does essentially nothing to testosterone — multiple null trials in replete subjects confirm this. D3 isn't a T-booster; it's a T-floor. If you're deficient, you're leaving free testosterone on the table, and that's the lever.
VDR in Skeletal Muscle: Strength and Contractile Function#
Skeletal muscle expresses VDR, and calcitriol signalling modulates myofiber size, calcium handling at the sarcoplasmic reticulum, and type II fiber development. This is why low 25(OH)D tracks with measurable performance decrements in otherwise healthy adults:
"Higher 25(OH)D was associated with greater grip strength (r = 0.22, p = 0.005) and muscle mass even after adjustment for age, sex, and body composition." — Grimaldi AS, Parker BA, Capizzi JA, et al., Medicine and Science in Sports and Exercise (2013)
Again — this is a deficiency-correction effect, not a pharmacological performance enhancer. Don't expect a PR from taking D3. Do expect to notice sluggish lifts and slower recovery if your 25(OH)D drops below 20 ng/mL over a dark winter.
Calcium Trafficking and the K2 Rationale#
Calcitriol's oldest and best-characterized job is upregulating intestinal calcium absorption (via TRPV6 and calbindin) and, alongside PTH, mobilizing calcium from bone when serum levels drop. At physiological 25(OH)D, this works cleanly. At chronically elevated 25(OH)D without adequate cofactors, the concern is where the absorbed calcium ends up — bone matrix (good) versus arterial intima and soft tissue (bad).
This is the mechanistic basis for the community's reflexive K2 pairing. Vitamin K2 (MK-4 or MK-7) activates matrix Gla protein (MGP) and osteocalcin, which bind calcium and direct it into bone rather than vasculature. Magnesium is a cofactor for both the hepatic and renal hydroxylase enzymes and for VDR function itself — which is why the standard stack is D3 + K2 + magnesium, not D3 alone. The mechanism is sound; the hard outcome data on K2 preventing calcification is thinner than the forum consensus suggests, but the biochemistry is coherent and the downside of adding K2 is essentially zero.
Dose-Response and Why Your Dose Isn't Your Neighbour's#
Serum 25(OH)D rises roughly linearly with intake in lean subjects:
"Serum 25(OH)D increased on average by 1.0 ng/mL (2.5 nmol/L) for each additional 100 IU/day of vitamin D3 supplementation in lean subjects." — Shab-Bidar S, Bours S, Geusens PP, et al., Nutrition (2014)
So 5,000 IU/day should, in a lean 80 kg male starting from ~20 ng/mL, land around 60–70 ng/mL at steady state. In a 110 kg bodybuilder with meaningful adipose mass, the same dose might only land at 35–40 ng/mL because of sequestration in fat tissue. This is why community high-dose protocols (8,000–10,000 IU/day) exist and why blind dosing without bloodwork is guessing. Pull 25(OH)D at 8–12 weeks, aim for 40–60 ng/mL, and adjust from there.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 1000–2000 IU | Once daily | Documented entry-level range |
| Mid | 4000–5000 IU | Once daily | Most commonly studied range |
| High | 8000–10000 IU | Once daily | Administer with a meal containing ≥10g fat — D3 is lipophilic and absorption drops materially on an empty stomach or fat-free meal. Oil-based softgels outperform dry tablets. Weekly dosing (e.g. 35,000 IU once weekly) also works due to the ~15-day half-life of 25(OH)D. |
Cycle length & outcomes
Documented cycle
8–52 weeks
Plateau after
12 wks
Cycle Length & Protocol#
Vitamin D3 isn't a "cycle" in the traditional sense — it's a year-round baseline supplement that takes 8–12 weeks to plateau in the blood and then stays there as long as you keep dosing. The "length" question really means how long until 25(OH)D stabilizes and you can stop thinking about it.
"Serum 25(OH)D increased on average by 1.0 ng/mL (2.5 nmol/L) for each additional 100 IU/day of vitamin D3 supplementation in lean subjects." — Shab-Bidar 2014, Nutrition
That dose-response math is the whole protocol: pick a target, divide by 25, and that's your daily IU above baseline. Lean guys starting at 20 ng/mL who want 50 ng/mL need roughly +3,000 IU/day. Obese or heavily muscled users should plan on 2–3× that dose because adipose sequesters D3.
Dose Ladder by Goal#
| Goal | Cycle Length | Daily Dose |
|---|---|---|
| General baseline / maintenance | Year-round | 2,000–5,000 IU |
| On-cycle support (AAS blast/cruise) | Run alongside cycle + indefinitely | 5,000 IU |
| Correcting documented deficiency (<20 ng/mL) | 8 weeks loading, then drop to maintenance | 10,000 IU → 5,000 IU |
| Winter / high latitude / indoor lifestyle | Oct–Mar | 8,000–10,000 IU |
| Obese (BMI >30) or heavy lean mass | Year-round | 8,000–10,000 IU |
| Testosterone optimization in deficient men | 12+ months | 3,000–5,000 IU |
Loading vs. Maintenance#
There is no loading phase in the AAS sense, but there is a kinetic lag. Parent D3 clears in ~24h, but 25(OH)D — the storage form labs measure — has a half-life of ~15 days. That means:
- Week 1–2: serum 25(OH)D is barely moving
- Week 4–8: rising linearly toward new steady-state
- Week 8–12: plateau — this is when you pull bloodwork
If you're starting from documented deficiency and want to front-load, 10,000 IU/day for 8 weeks is the community standard and is well within the safety envelope.
"No adverse effects have been reported in clinical trials with serum 25(OH)D levels up to 220 nmol/L or with daily intakes up to 10,000 IU in healthy adults." — Hathcock et al. 2007, Am J Clin Nutr
After loading, drop to 5,000 IU/day indefinitely. No taper, no washout — D3 isn't suppressive, has no rebound, and doesn't require cycling off.
Onset Timing — What to Expect When#
- Testosterone response (in deficient men): measurable by ~12 weeks, fully expressed by 6–12 months.
"A significant increase in total testosterone levels was observed in the vitamin D supplemented group (from 10.7 ± 3.9 to 13.4 ± 4.7 nmol/l, p < 0.001), whereas in the placebo group there was no significant change." — Pilz et al. 2011, Hormone and Metabolic Research
- Mood / sleep / immune feel: 2–4 weeks in deficient users, subtle or absent in replete ones.
- Grip strength / performance markers: correlational rather than acute — if you're deficient and correct it, there's a real floor being raised, but don't expect a PR bump.
"Higher 25(OH)D was associated with greater grip strength (r = 0.22, p = 0.005) and muscle mass even after adjustment for age, sex, and body composition." — Grimaldi et al. 2013, Med Sci Sports Exerc
- Bloodwork visibility: 25(OH)D rises detectably at 7 days, stabilizes at 8–12 weeks.
Key honest point: if you're already replete (>40 ng/mL), adding more D3 does not give you a testosterone boost, a strength boost, or anything else. The upside is entirely in the deficient-to-replete window. Chasing 80+ ng/mL is diminishing-returns territory.
Bloodwork Cadence#
This is the one supplement where bloodwork genuinely matters, because response varies 3–4× between individuals.
| Timepoint | Pull | Purpose |
|---|---|---|
| Baseline (before starting) | 25(OH)D, calcium | Establish starting point, rule out hypercalcemia |
| Week 8–12 | 25(OH)D, calcium | Confirm you're in the 40–60 ng/mL target |
| Annually thereafter | 25(OH)D, calcium | Seasonal drift, dose adjustment |
| If dosing >10,000 IU/day | Add every 3–6 months | Monitor for hypercalciuria |
On-cycle users already pulling quarterly panels (lipids, CMP, E2, T) should just add 25(OH)D to the standing order — it's a ~$30 add-on and answers the question definitively.
Tapering & Cycling Off#
Don't. D3 has no suppression, no rebound, no tolerance, no receptor downregulation concern at physiological doses. The only reason to stop is documented hypercalcemia, new diagnosis of sarcoidosis or granulomatous disease, or starting high-dose thiazide therapy — at which point you stop outright, not taper.
If you do stop, 25(OH)D declines with a ~15-day half-life and you'll be back to baseline deficiency in 2–3 months. This is a forever supplement, not a cycle.
Risks & mistakes
Common (most users)#
At standard doses (1,000–5,000 IU/day with a fatty meal), D3 is genuinely uneventful. The "side effects" people report are almost always cofactor mismatches or absorption issues rather than D3 itself:
- Nothing at all — this is the honest answer for the vast majority of users at ≤5,000 IU/day. D3 is one of the best-tolerated compounds you'll run.
- Mild GI upset or nausea — almost always from taking it on an empty stomach or with a fat-free meal. Fix: pair with ≥10 g fat (eggs, nut butter, olive oil, fatty fish). Oil-based softgels cause fewer complaints than dry tablets.
- Muscle cramps or twitchy calves — usually a magnesium issue, not D3 toxicity. Running D3 increases magnesium utilization; if you're already borderline, 5,000 IU/day can expose it. Add 200–400 mg elemental magnesium (glycinate or malate) at night.
- Headaches or a "wired" feeling on high doses — occasionally reported when ramping to 10,000 IU/day. Usually resolves once 25(OH)D plateaus. Drop back to 5,000 IU if it persists.
- No HPTA suppression, no aromatization, no liver stress, no hair shedding — D3 doesn't operate on those axes at sane doses.
Uncommon (dose-dependent or individual)#
These show up at sustained high doses or in users who skip bloodwork:
- Hypercalciuria (elevated urinary calcium) — the most common lab finding at chronic 10,000 IU/day dosing. Usually subclinical.
"Doses of 10,000 IU/day for 3 years resulted in higher rates of hypercalciuria compared to 400 and 4,000 IU/day; however, clinically significant hypercalcemia was rare and occurred in all groups." — Billington 2020, J Clin Endocrinol Metab
Mitigation: recheck serum calcium and 25(OH)D at 8–12 weeks on any dose ≥5,000 IU/day. If 25(OH)D is above 80–100 ng/mL, drop the dose.
- Over-shooting 25(OH)D past 100 ng/mL — diminishing returns above 60 ng/mL and rising hypercalciuria risk. The target is 40–60 ng/mL, not "as high as possible."
- Soft-tissue calcification concern on high-dose D3 without K2 — mechanistic rather than proven, but the community pairs K2 (MK-7 ~100 mcg per 5,000 IU D3) as cheap insurance to direct calcium to bone rather than arteries.
- Under-response in obese or heavy-muscled users — not a side effect per se, but worth flagging. Adipose sequesters D3; BMI >30 typically needs 2–3× the standard dose to hit the same serum target.
"Serum 25(OH)D increased on average by 1.0 ng/mL (2.5 nmol/L) for each additional 100 IU/day of vitamin D3 supplementation in lean subjects." — Shab-Bidar 2014, Nutrition
Rare but serious#
These are real but essentially restricted to mega-dosers without bloodwork or users with underlying pathology:
- Frank hypercalcemia — nausea, vomiting, polyuria, polydipsia, confusion, cardiac arrhythmias. Almost always requires sustained dosing well above 40,000 IU/day or an underlying CYP24A1 mutation.
"Vitamin D intoxication is observed most commonly after high chronic intakes and is characterized by hypercalcemia, hypercalciuria, and suppressed PTH concentration." — Jones 2008, Am J Clin Nutr
Warning signs: new-onset kidney stones, unexplained nausea, cognitive fog, frequent urination. Stop D3 immediately and pull calcium + 25(OH)D + PTH.
- Nephrocalcinosis / kidney stones — secondary to chronic hypercalciuria. Hydrate well; test if symptomatic.
- Arrhythmias — downstream of severe hypercalcemia. Rare without extreme dosing.
For reference on the safety ceiling at sensible doses:
"No adverse effects have been reported in clinical trials with serum 25(OH)D levels up to 220 nmol/L or with daily intakes up to 10,000 IU in healthy adults." — Hathcock 2007, Am J Clin Nutr
Hard contraindications#
These are lines that do not get crossed — in these populations, even modest D3 intake can trigger severe hypercalcemia because the normal regulatory feedback on 1,25(OH)₂D production is broken:
- Sarcoidosis and other granulomatous diseases (tuberculosis, berylliosis, granulomatous Crohn's) — activated macrophages produce 1,25(OH)₂D without PTH control. Do not supplement without endocrinology supervision.
- Lymphoma — some B-cell lymphomas behave similarly.
- Primary hyperparathyroidism — already hypercalcemic; adding D3 makes it worse.
- Pre-existing hypercalcemia of any cause — fix the underlying issue first.
- High-dose thiazide diuretics — thiazides reduce urinary calcium excretion; stacking with high-dose D3 stacks hypercalcemia risk. Monitor or keep D3 at maintenance doses only.
- Known CYP24A1 loss-of-function mutations (idiopathic infantile hypercalcemia persisting into adulthood) — rare, but these users can't degrade active D and should not supplement without specialist input.
Gender, pregnancy, and PCT#
D3 is gender-neutral — women dose identically to men (4,000–5,000 IU/day maintenance, bloodwork-driven adjustment). It does not virilize, does not suppress menstrual function, and has no anabolic-hormonal gender angle.
Pregnancy: D3 is not contraindicated in pregnancy — it's actively recommended (600–4,000 IU/day is considered safe in pregnant women). This is one of the few compounds in the physique toolkit that doesn't require dose adjustment or cessation for pregnancy or conception planning.
PCT: No role. D3 doesn't suppress the HPTA and doesn't need to be cycled off. Keep it running year-round regardless of cycle status — if anything, correcting deficiency during PCT helps natural T recovery land higher, given the Leydig-cell VDR data.
"A significant increase in total testosterone levels was observed in the vitamin D supplemented group (from 10.7 ± 3.9 to 13.4 ± 4.7 nmol/l, p < 0.001), whereas in the placebo group there was no significant change." — Pilz 2011, Horm Metab Res
Bottom line: at 5,000 IU/day with K2 and magnesium, paired with a fatty meal and an annual 25(OH)D check, D3 is about as low-risk as any compound in the stack. The side-effect profile only becomes interesting when users mega-dose blind or carry one of the hard contraindications above.
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| synergistic | ×1.00 | ×1.00 | ×1.15 |
FAQ — Vitamin D3
Research & citations
6 studies cited on this page.
Conclusion
Vitamin D3 is one of the few near-universal baseline supplements in the physique and looksmaxxing worlds — cheap, safe, and legitimately moves the needle if you're deficient.
Key takeaways:
- 5,000 IU/day with a fatty meal is the default community dose; 8,000–10,000 IU/day for obese or heavy-muscled users
- Always pair with K2 (MK-7, 100–200 µg) and magnesium (200–400 mg glycinate) to handle calcium and maximize D3 benefits
- Expect roughly +1 ng/mL (2.5 nmol/L) in 25(OH)D per extra 100 IU/day at steady state (Shab-Bidar 2014)
- Pull 25(OH)D bloods at 8–12 weeks to land in 40–60 ng/mL (100–150 nmol/L) — adjust dose from there
- Deficiency correction can raise total testosterone and grip strength in low-baseline users (Pilz 2011; Grimaldi 2013)
- Side effects at ≤10,000 IU/day are rare; avoid if you have sarcoidosis, granulomatous disease, lymphoma, hypercalcemia, or are on high-dose thiazides
If you're inside under artificial light all day, consider D3 with K2 and magnesium your foundational 'insurance' stack — nothing flashy, but a true floor-raiser for T, immunity, and recovery.